17
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL CHALLENGEEditor: Steven Gans, MD

An Atypical, Chronic Psychotic Disorder in a 55-Year-Old Man

, MD, , MD, , MD, , MD, , MD & , PhD
Pages 329-343 | Received 06 Mar 2009, Accepted 03 Apr 2009, Published online: 15 Oct 2009

REFERENCES

  • Pope HG Jr, Yurgelun-Todd D. Schizophrenic individuals with bipolar first-degree relatives: analysis of two pedigrees. J Clin Psychiatry 1990;51:97–101.
  • Peralta V, Cuesta MJ. The relationship between syndromes of the psychotic illness and familial liability to schizophrenia and major mood disorders. Schizophr Res 2007;91:200–9.
  • Pope HG Jr, Lipinski JF Jr. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of ‘schizophrenic’ symptoms in the light of current research. Arch Gen Psychiatry 1978;35:811–28.
  • Kendler KS, Walsh D. Structure of psychosis: syndromes and dimensions. Arch Gen Psychiatry 1998;55:508–9.
  • Peralta V, Cuesta MJ. Nosology of psychotic disorders: comparison among competing classification systems. Schizophr Bull 2003;29:413–25.
  • Salvatore P, Khalsa HMK, Perez Sanchez-Toledo J, Tohen M, Maggini C, Baldessarini RJ. DSM-IV diagnostic stability in 500 first-episode psychotic disorder subjects. J Clin Psychiatry (2009, in press).
  • Salvatore P, Khalsa HMK, Perez Sanchez-Toledo J, Tohen M, Maggini C, Baldessarini RJ. ICD-10 diagnostic stability in 500 first-episode psychotic disorder subjects. Br J Psychiatry (2009, in press).
  • Trede K, Salvatore P, Baethge C, Gerhard A, Maggini C, Baldessarini RJ. Manic-depressive illness: evolution in Kraepelin's Textbook, 1883–1926. Harv Rev Psychiatry 2005;13:155–78.
  • Baldessarini RJ. American biological psychiatry and psychopharmacology, 1944–1994. In: Menninger RW, Nemiah JC, eds. American psychiatry after World War II (1944–1994). Washington, DC: American Psychiatric Press, 2000:371–412.
  • Schneider K. Primäre und sekundäre Symptome bei der Schizophrenie. Fortschr Neurol Psychiatrie 1957;25:487–90.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Arlington, VA: American Psychiatric Press, 2000.
  • World Health Organization. International classification of diseases. 10th rev. Geneva: WHO, 1992.
  • Bleuler E, Zinkin J, trans. Dementia praecox or the group of schizophrenias. New York: International Universities Press, 1950 [originally published 1911].
  • Fusar-Poli P, Politi P. Paul Eugen Bleuler and the birth of schizophrenia (1908). Am J Psychiatry 2008;165:1407.
  • Gross G, Huber G, Klosterkoetter J, Linz M. BSABS. Bonner Skala für die Beurteilung von Basissymptomen [Bonn Scale for Assessment of Basic Symptoms]. Heidelberg: Springer, 1987.
  • Peralta V, Cuesta MJ. Clinical models of schizophrenia: a critical approach to competing conceptions. Psychopathology 2000;33:252–8.
  • Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 2001;49:269–85.
  • Peralta V, Cuesta MJ. Clinical models of schizophrenia: critical approach to competing conceptions. Psychopathology 2000;33:252–8.
  • Gross G, Huber G. [Schizophrenia: neurodevelopmental disorder or degenerative brain process?]. Fortschr Neurol Psychiatr 2008;76 suppl 1:S57–62.
  • Penland HR, Weder N, Tampi RR. The catatonic dilemma expanded. Ann Gen Psychiatry 2006;5:1–16.
  • Kahlbaum KL. Catatonia. Baltimore, MD: Johns Hopkins University Press, 1973. [trans. of: Die Katatonie oder das Spannungsirresein. Berlin: Hirschwald, 1874].
  • Sarkstein SE, Golar JC, Hodgkiss A. Karl Ludwig Kahlbaum's concept of catatonia. Hist Psychiatry 1995;6:201–7.
  • Huang T, Ree S, Huang Y, Liu J, Yang Y. Catatonic features: differential diagnosis and treatment at an emergency unit. Psychiatry Clin Neurosci 1999;53:63–6.
  • van der Heijden FM, Tuinier S, Hoogendoorn MLC, Kahn RS, Verhoeven WMA. Catatonia: disappeared or under-diagnosed? Psychopathology 2005;38:3–8.
  • Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia: rating scale for standardized examination. Acta Psychiatr Scand 1996;93:129–36.
  • Bräunig P, Krüger A, Shugar G, Höffer J, Börner I. Catatonia rating scale: development, reliability and use. Compr Psychiatry 2000;41:147–58.
  • Krüger S, Bräunig P. Catatonia in affective disorder: new findings and review of the literature. CNS Spectr 2000;5:48–53.
  • Pfuhlmann B, Stober G. Different conceptions of catatonia: historical overview and critical discussion. Eur Arch Psychiatry Clin Neurosci 2001;251 suppl 1:14–7.
  • Weder ND, Muralee S, Penland H, Tampi RR. Catatonia: a review. Ann Clin Psychiatry 2008;20:97–107.
  • Gelenberg AJ, Mandel MR. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977;34:947–50.
  • Dose M. Neuroleptic-induced pseudo-catatonia. Pharmacopsychiatry 2001;34:262–4.
  • Caroff SN, Mann SC, Campbell EC, Sullivan KA. Movement disorders associated with atypical antipsychotic drugs. J Clin Psychiatry 2002;63 suppl 4:12–9.
  • Hesslinger B, Walden J, Normann C. Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry 2001;34:25–6.
  • Hung YY, Yang PS, Huang TL. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases. Psychiatry Clin Neurosci 2006;6:256–8.
  • Babington PW, Spiegel DR. Treatment of catatonia with olanzapine and amantadine. Psychosomatics 2007;48:534–6.
  • Hasan S, Buckley P. Novel antipsychotics and neuroleptic malignant syndrome: review and critique. Am J Psychiatry 1998;155:1113–6.
  • Gibson RC, Walcott G. Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses. Cochrane Database Syst Rev 2008; (4):CD006570.
  • Deutschle M, Lederbogen F. Benzodiazepine-withdrawal-induced catatonia. Pharmacopsychiatry 2001;34:41–2.
  • Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci 2001;251 suppl 1:18–13.
  • Malur C, Pasol E, Francis A. ECT for prolonged catatonia. J ECT 2001;17:55–9.
  • Suzuki K, Awata S, Matsuuoka J. Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J ECT 2003;19:73–80.
  • Bloch Y, Sobol D, Levkovitz Y, Kron S, Ratzoni G. Reasons for referral for electroconvulsive therapy: a comparison between adolescents and adults. Australas Psychiatry 2008;16:191–4.
  • Wilkins KM, Ostroff R, Tampi RR. Efficacy of electroconvulsive therapy in treatment of nondepressed psychiatric illness in elderly patients: review of the literature. J Geriatr Psychiatry Neurol 2008;21:3–11.
  • McDaniel WW, Spiegel DR, Sahota AK. Topiramate effect in catatonia: case series. J Neuropsychiatry Clin Neurosci 2006;18:234–8.
  • Babington PW, Spiegel DR. Treatment of catatonia with olanzapine and amantadine. Psychosomatics 2007;48:534–6.
  • Carroll BT, Goforth HW, Thomas C, Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 2007;19:406–12.
  • McWilliams N. Psychoanalytic diagnosis. New York: Guilford, 1994.
  • Shakespeare W. The most excellent and lamentable tragedy of Romeo and Juliet. New Haven, CT: Yale University Press, 1954.
  • MacFarlane WR, Link B, Dushay R, Marchal J, Crilly J. Psychoeducational multiple-family groups: four-year relapse outcome in schizophrenia. Fam Process 1995;34:127–44.
  • MacFarlane WR, Lukens E, Link B, Dushay R, Deakins SA. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995;52:679–87.
  • Dyck DG, Hendryx MS, Short RA, Voss WD, MacFarlane WR. Service use among patients with schizophrenia in psychoeducational multi-family group treatment. Psychiatr Serv 2002;53:749–54.
  • Payson AA, Wheeler K, Wellington TA. Health teaching needs of clients with serious and persistent mental illness: client and provider perspectives. J Psychosoc Nurs Ment Health Serv 1998;36:32–5.
  • Huxley NA, Rendall M, Sederer L. Psychosocial treatments in schizophrenia: a review of the past 20 years. J Nerv Ment Dis 2000;188:187–201.
  • Bales RF, Cohen SP. SYMLOG: a system for the multiple level observation of groups. New York: Free, 1979.
  • Polley RB, Hare AP, Stone P, eds. The SYMLOG practitioner: applications of small group research. New York: Praeger, 1988.
  • Bales RF. Social interaction systems: theory and measurement. New Brunswick, NJ: Transaction, 1999.
  • Hare AP, Sjovold E, Baker HG, Powers JP, eds. Analysis of social interaction systems: SYMLOG research and applications. Dallas, TX: University Press of America, 2005.
  • Hare AP, Hare Sharon, eds. SYMLOG field theory: organizational consultation, value differences, personality and social perception. Westport, CT: Praeger, 1996.
  • Powers JP. Social relations evaluation and treatment: cognitive feedback for families, couples, groups, and individuals. In: Hare AP, Sjoveld E, Baker HG, Powers JP, eds. Analysis of social interactions systems: SYMLOG research and applications. Dallas, TX: University Press of America, 2005: 233–9.
  • Bales RF. Overview of the SYMLOG system: measuring and changing behavior in groups. San Diego, CA: SYMLOG Consulting Group, 1983.
  • Bales RF, Koenigs RJ. Images that guide leadership: the SYMLOG Reference Field Diagram. San Diego, CA: SYMLOG Consulting Group, 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.